ATE113271T1 - Halogensubstituierte aminotetraline. - Google Patents
Halogensubstituierte aminotetraline.Info
- Publication number
- ATE113271T1 ATE113271T1 AT90901708T AT90901708T ATE113271T1 AT E113271 T1 ATE113271 T1 AT E113271T1 AT 90901708 T AT90901708 T AT 90901708T AT 90901708 T AT90901708 T AT 90901708T AT E113271 T1 ATE113271 T1 AT E113271T1
- Authority
- AT
- Austria
- Prior art keywords
- halogen
- alkyl
- hydrogen
- thiophene
- cycloalkyl
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- 150000002367 halogens Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 150000002431 hydrogen Chemical group 0.000 abstract 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 125000005329 tetralinyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29516989A | 1989-01-09 | 1989-01-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE113271T1 true ATE113271T1 (de) | 1994-11-15 |
Family
ID=23136530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90901708T ATE113271T1 (de) | 1989-01-09 | 1990-01-03 | Halogensubstituierte aminotetraline. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0452390B1 (de) |
| JP (1) | JP2868897B2 (de) |
| KR (1) | KR910700225A (de) |
| AT (1) | ATE113271T1 (de) |
| AU (1) | AU4844290A (de) |
| CA (1) | CA2026775C (de) |
| DE (1) | DE69013672T2 (de) |
| DK (1) | DK0452390T3 (de) |
| WO (1) | WO1990007490A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5177112A (en) * | 1983-01-03 | 1993-01-05 | Whitby Research, Inc. | Substituted 2-aminotetralins |
| FR2633617B1 (fr) * | 1988-07-04 | 1991-02-08 | Adir | Nouveaux derives du benzocycloheptene, leur procede de preparation et les compositions pharmaceutiques les renfermant |
| IL109647A (en) * | 1989-02-27 | 1997-04-15 | Lilly Co Eli | Intermediate compounds for ring-substituted 2-amino-1, 2, 3, 4-tetra- hydronaphthalenes and 3-aminochromanes |
| SE8901889D0 (sv) * | 1989-05-26 | 1989-05-26 | Astra Ab | Novel 8-substituted-2-aminotetralines |
| CA2051399C (en) * | 1989-05-31 | 2003-12-30 | Chiu-Hong Lin | Therapeutically useful 2-aminotetralin derivatives |
| SE8904127D0 (sv) * | 1989-12-07 | 1989-12-07 | Astra Ab | New biocyclic amino-substituted compounds |
| FR2669821A1 (fr) * | 1990-12-04 | 1992-06-05 | Sanofi Sa | Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression. |
| WO1995004713A1 (en) * | 1993-08-06 | 1995-02-16 | The Upjohn Company | 2-aminoindans as selective dopamine d3 ligands |
| WO1996015099A1 (en) * | 1994-11-09 | 1996-05-23 | Novo Nordisk A/S | Heterocyclic compounds, their preparation and use |
| PT807101E (pt) * | 1995-02-01 | 2001-12-28 | Upjohn Co | 2-aminoindanos comoligandos selectivos de dopamina d3 |
| KR101381768B1 (ko) * | 2006-01-06 | 2014-04-07 | 선오비온 파마슈티컬스 인코포레이티드 | 테트랄론-기재 모노아민 재흡수 저해제 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1518652A1 (de) * | 1965-05-29 | 1969-04-10 | Albert Ag Chem Werke | Verfahren zur Herstellung von pharmazeutisch wirksamen Derivaten des 2-Aminoindans |
| DE2803582A1 (de) * | 1978-01-27 | 1979-08-02 | Sandoz Ag | Neue tetralinderivate, ihre herstellung und verwendung |
| US4192888A (en) * | 1978-04-10 | 1980-03-11 | Smithkline Corporation | Pharmaceutical compositions and method of inhibiting phenylethanolamine N-methyltransferase |
| SE8004002L (sv) * | 1980-05-29 | 1981-11-30 | Arvidsson Folke Lars Erik | Terapeutiskt anvendbara tetralinderivat |
| US4320148A (en) * | 1980-11-24 | 1982-03-16 | Smithkline Corporation | 2-Aminotetralin compounds, pharmaceutical compositions and method of producing central alpha1 agonist activity |
| DE3719924A1 (de) * | 1986-12-22 | 1988-06-30 | Bayer Ag | 8-substituierte 2-aminotetraline |
-
1990
- 1990-01-03 AU AU48442/90A patent/AU4844290A/en not_active Abandoned
- 1990-01-03 WO PCT/US1990/000015 patent/WO1990007490A1/en not_active Ceased
- 1990-01-03 JP JP2502272A patent/JP2868897B2/ja not_active Expired - Lifetime
- 1990-01-03 DE DE69013672T patent/DE69013672T2/de not_active Expired - Fee Related
- 1990-01-03 EP EP90901708A patent/EP0452390B1/de not_active Expired - Lifetime
- 1990-01-03 CA CA002026775A patent/CA2026775C/en not_active Expired - Fee Related
- 1990-01-03 AT AT90901708T patent/ATE113271T1/de not_active IP Right Cessation
- 1990-01-03 KR KR1019900701993A patent/KR910700225A/ko not_active Ceased
- 1990-01-03 DK DK90901708.9T patent/DK0452390T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| AU4844290A (en) | 1990-08-01 |
| KR910700225A (ko) | 1991-03-14 |
| WO1990007490A1 (en) | 1990-07-12 |
| EP0452390A1 (de) | 1991-10-23 |
| CA2026775C (en) | 1998-04-07 |
| DE69013672T2 (de) | 1995-03-30 |
| EP0452390B1 (de) | 1994-10-26 |
| DK0452390T3 (da) | 1995-04-03 |
| CA2026775A1 (en) | 1990-07-10 |
| JPH04502620A (ja) | 1992-05-14 |
| DE69013672D1 (de) | 1994-12-01 |
| JP2868897B2 (ja) | 1999-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2062009T4 (es) | Agentes antifungicos derivados de triazol | |
| DE69013672D1 (de) | Halogensubstituierte aminotetraline. | |
| HU9300898D0 (en) | Non-aromatic heterocyclic compounds containing condensed nitrogenb | |
| DK0494978T3 (da) | Heterocycliske forbindelser | |
| NZ334600A (en) | Thienopyrimidines inhibiting phosphodiesterase V for treating cardiovascular disease and impotency | |
| DE69129009D1 (de) | Indole Derivate als Serotonin-Antagonisten | |
| SE7906722L (sv) | Merkaptoacylderivat av substituerade proliner | |
| NO873568L (no) | Alfa-alkyl-4-amino-kinolinmetanoler og 1-(4-aralkylamino-3-kinolinyl)alkanoler, samt fremgangsmaate for fremstilling derav. | |
| ATE143806T1 (de) | Verbesserungen von oder in bezug auf exzitatorische aminosäurenrezeptorantagonisten | |
| NO305287B1 (no) | AMPA antagonister | |
| DE69010285D1 (de) | Als Spasmolytica geeignete Dibenzothiazepin-Derivate. | |
| ATE101147T1 (de) | Pharmazeutisch verwendbare polymorphe modifikation von buspiron. | |
| NO874872L (no) | Kondenderte heterocykliske tetrahydroaminokinolinoler og beslektede forbindelser samt fremgangsmaate for fremstilling derav. | |
| MX9205374A (es) | Piridinil-amino-1h-indoles, 1h-indazoles, 2h-indazoles, benzo(b)tiofenos y 1,2-benzo-isotiazoles sustituidos, un procedimiento para su preparacion y su utilizacion como medicamentos. | |
| FI99014B (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten bentsotieno[2,3-b]pyratsiini-2,3(1H,4H)-dionien valmistamiseksi | |
| ATE124697T1 (de) | Azabicyclische derivate mit affinität am muskarine rezeptor. | |
| NZ333229A (de) | ||
| ATE56944T1 (de) | Substituierte 2-aminotetraline. | |
| ES2064533T3 (es) | Acido(1,2,3,4-tetrahidro-9-acridinimino)-ciclohexanocarboxilico y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos. | |
| DE58902320D1 (de) | Thienyl-piperazinone, ihre herstellung und verwendung. | |
| ES2096800T3 (es) | Benzo(b)tiofen-3-il-piperazinas, un procedimiento para su preparacion y su uso como medicamentos. | |
| MX25922A (es) | Pirido (3,4-b) pirrolo (1,2-e)(1,4,5)oxadiazepinasy compuestos analogos relacionados un procedimiento para su preparacion y su uso como medicamentos | |
| FI902851A0 (fi) | 4,5,5a,6-tetrahydro-3h-isoxazolo/5,4,3 -kl/akridinderivat, foerfarande foer deras framstaellande och deras anvaendning som laekemedel. | |
| ES483299A1 (es) | Un procedimiento para la preparacion de derivados de benzo- diacepina | |
| ECSP993274A (es) | Antagonistas de receptor de nk1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |